MarketPeel
EVP R&D, Chief Medical Officer
Mon, Dec 9, 2024
Dec 9
exercised or converted securities in ALKS
12,044 shares @ $24.59
Increased holdings by +14.30%
Net across this filing: -20.30% (-12,154 shares)
Option Exercise
Sale tied to a same-time option exercise
ALKSAlkermes plc.
Health CarePharmaceuticals
1D0.00%
1W-3.05%
1M-8.62%
3M+29.40%
6M
1Y

Recent insider activity at ALKS

FREE · DAILY · 6 AM ET

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback